BIOXYTRAN, INC. (BIXT)
Bioxytran Reports Encouraging Clinical Observations in First Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patient Treated with PLICID, a Novel Galectin Antagonist Designed with Artificial Intelligence
Bioxytran Reports Encouraging Clinical Observations in First Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patient Treated with PLICID, a Novel Galectin Antagonist Designed with Artificial Intelligence
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
VinSpace Announces Launch Contract with SpaceX, Marking a New Milestone for Vietnams Space Industry
XTI Aerospace Postpones Release of Second Quarter 2026 Financial Results
Xtant Medical Reports Second Quarter 2026 Financial Results
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
Philadelphia Cream Cheese and Ziggis Coffee Reimagine a Beloved Breakfast Duo with First-Ever Philadelphia Everything Bagel Latte
WIX Stockholders Have Rights - If You Lost Money Investing in Wix.com Ltd. Contact Robbins LLP for Information About Recovering Your Losses
Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Beamr Issues Q2-2026 CEO Letter to Shareholders: Expanding Our Reach into Autonomous Vehicle Teams